Supplies reliable pharmaceutical products for epilepsy, stroke, and pain management.
Annual revenue $3.1M Latest available
Total funding - Funding intelligence
Employees 166 Tracked headcount
Investors - Known backers
Products 5 Services tracked
Competitors - Brand Intelligence

About Lyceumworld

Lyceumworld is a company based in India. It operates as a B2B. The company has 166 employees as of March 31, 2023. Lyceumworld offers products and services including Epilepsy Medicines, Stroke Medicines, Pain Relief Drugs, GERD Treatments, and Antibiotics.

  • Headquarter India
  • Employees 166 as on 31 Mar, 2023
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Lyceum Life Sciences Private Limited
  • Date of Incorporation 21 Jun, 2019
  • Jurisdiction Sanand, Gujarat, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $3.07 M (USD)
    112.28
    as on Mar 31, 2023
  • Net Profit
    $109.66 K (USD)
    118.44
    as on Mar 31, 2023
  • EBITDA
    $156.61 K (USD)
    89.9
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    166

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Lyceumworld

Lyceumworld offers a comprehensive portfolio of products and services, including Epilepsy Medicines, Stroke Medicines, Pain Relief Drugs, GERD Treatments, and Antibiotics.

Product name locked
Category locked
Primary

Treatments for managing epilepsy and related neurological conditions

Product name locked
Category locked
Locked

Medications for stroke prevention and recovery support

Product name locked
Category locked
Locked

Products for effective pain management and relief

Product name locked
Category locked
Locked

Solutions for gastroesophageal reflux disease symptoms

Product name locked
Category locked
Locked

Antibacterial agents for treating various infections

Funding Insights of Lyceumworld

Premium access

Detailed funding history for Lyceumworld

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Lyceumworld

Investments
Premium access

Investment portfolio details for Lyceumworld

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Lyceumworld

Premium access

Detailed financials for Lyceumworld

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Lyceumworld Comparisons

Lyceumworld Primary company
Description
Supplies reliable pharmaceutical products for epilepsy, stro...
Location
India
Founded Year
-
Annual Revenue
$3.07 M (USD)
Net Profit
$109.66 K (USD)
EBITDA
$156.61 K (USD)
Employees
166
As of 2023
Premium access

Peer comparison for Lyceumworld

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Lyceumworld

Premium access

Detailed competitors of Lyceumworld

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Lyceumworld

Premium access

Complete news archive for Lyceumworld

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lyceumworld

Lyceumworld is headquartered in India.

As of Mar 31, 2023, the latest employee count at Lyceumworld is 166.

Annual revenue of Lyceumworld is $3.07M as on Mar 31, 2023.

Lyceum Life Sciences is a pharmaceutical company focused on delivering quality and affordable medicines for conditions like epilepsy, stroke, pain, GERD, antibiotics, and antioxidants. Based in Ahmedabad, India, they procure products from premium manufacturers and ensure compliance with international standards. They serve doctors, patients, and business associates through reliable distribution and marketing efforts, emphasizing patient-centered healthcare solutions.

Lyceumworld offers Epilepsy Medicines, Stroke Medicines, Pain Relief Drugs, GERD Treatments, and Antibiotics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available